View Future GrowthSOL 과거 순이익 실적과거 기준 점검 5/6SOL은 연평균 10.4%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 4.4% 감소했습니다. 매출은 연평균 11.6%의 비율로 증가했습니다. SOL의 자기자본이익률은 14.8%이고 순이익률은 9.2%입니다.핵심 정보10.36%순이익 성장률10.36%주당순이익(EPS) 성장률Chemicals 산업 성장률12.41%매출 성장률11.57%자기자본이익률14.79%순이익률9.23%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 22%After last week's 22% share price gain to €59.40, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 145% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €24.91 per share.공지 • Mar 30SOL S.p.A., Annual General Meeting, May 12, 2026SOL S.p.A., Annual General Meeting, May 12, 2026, at 11:00 W. Europe Standard Time.Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.공지 • Mar 27SOL S.p.A. announces Annual dividend, payable on May 20, 2026SOL S.p.A. announced Annual dividend of EUR 0.4500 per share payable on May 20, 2026, ex-date on May 18, 2026 and record date on May 19, 2026.New Risk • Sep 18New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Share price has been volatile over the past 3 months (7.3% average weekly change).Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • May 12Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 19 May 2025. Payment date: 21 May 2025. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (3.9%).Declared Dividend • Mar 31Dividend increased to €0.39Dividend of €0.39 is 5.4% higher than last year. Ex-date: 19th May 2025 Payment date: 21st May 2025 Dividend yield will be 1.1%, which is lower than the industry average of 6.1%. Sustainability & Growth The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 32% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공지 • Mar 30SOL S.p.A. announces Annual dividend, payable on May 21, 2025SOL S.p.A. announced Annual dividend of EUR 0.3900 per share payable on May 21, 2025, ex-date on May 19, 2025 and record date on May 20, 2025.Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.Upcoming Dividend • May 13Upcoming dividend of €0.37 per shareEligible shareholders must have bought the stock before 20 May 2024. Payment date: 22 May 2024. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%).New Risk • Mar 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Sep 17New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 47% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.Upcoming Dividend • May 15Upcoming dividend of €0.33 per share at 1.2% yieldEligible shareholders must have bought the stock before 22 May 2023. Payment date: 24 May 2023. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%).Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Sep 18Second quarter 2022 earnings released: EPS: €0.35 (vs €0.26 in 2Q 2021)Second quarter 2022 results: EPS: €0.35 (up from €0.26 in 2Q 2021). Revenue: €357.9m (up 28% from 2Q 2021). Net income: €32.1m (up 36% from 2Q 2021). Profit margin: 9.0% (up from 8.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • May 09Upcoming dividend of €0.24 per shareEligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (4.2%). Lower than average of industry peers (5.2%).Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공지 • Apr 08SOL S.p.A. announced that it has received €75 million in funding from The Prudential Insurance Company of America, Prudential Legacy Insurance Company of New Jersey, Prudential Term Reinsurance Company, Pruco Life Insurance Company, Gibraltar Universal Life Reinsurance CompanyOn April 6, 2022, SOL S.p.A. closed the transaction.Reported Earnings • Sep 18Second quarter 2021 earnings released: EPS €0.26 (vs €0.23 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: €280.7m (up 17% from 2Q 2020). Net income: €23.7m (up 15% from 2Q 2020). Profit margin: 8.4% (down from 8.6% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 18Full year 2020 earnings released: EPS €1.19 (vs €0.58 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €987.1m (up 7.5% from FY 2019). Net income: €108.2m (up 107% from FY 2019). Profit margin: 11% (up from 5.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • May 17Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 24 May 2021. Payment date: 26 May 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.3%). Lower than average of industry peers (3.6%).Upcoming Dividend • May 10Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 17 May 2021. Payment date: 19 May 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.5%).Is New 90 Day High Low • Feb 19New 90-day high: €15.55The company is up 30% from its price of €11.95 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Jan 26New 90-day high: €14.25The company is up 31% from its price of €10.90 on 27 October 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period.Is New 90 Day High Low • Jan 05New 90-day high: €14.10The company is up 18% from its price of €12.00 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.Is New 90 Day High Low • Dec 07New 90-day high: €12.90The company is up 25% from its price of €10.35 on 08 September 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Nov 19New 90-day high: €12.05The company is up 15% from its price of €10.45 on 21 August 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Oct 07New 90-day high: €12.00The company is up 17% from its price of €10.30 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Sep 18New 90-day high: €11.15The company is up 9.0% from its price of €10.20 on 19 June 2020. The German market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period.매출 및 비용 세부 내역SOL가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BST:QOL 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 251,810167384030 Sep 251,776162192030 Jun 251,7351560031 Mar 251,6871520031 Dec 241,6401480030 Sep 241,5971440030 Jun 241,5631410031 Mar 241,5441430031 Dec 231,5251460030 Sep 231,5051470030 Jun 231,4851490031 Mar 231,4551410031 Dec 221,4251340030 Sep 221,3461190030 Jun 221,2661040031 Mar 221,199970031 Dec 211,132900030 Sep 211,0941020030 Jun 211,0561150031 Mar 211,0221090031 Dec 209871030030 Sep 20966830030 Jun 20945650031 Mar 20932590031 Dec 19919520030 Sep 19899490030 Jun 19880490031 Mar 19863510031 Dec 18845520030 Sep 18828520030 Jun 18810510031 Mar 18789460031 Dec 17768400030 Sep 17752410030 Jun 17736420031 Mar 17726430031 Dec 16715440030 Sep 16708400030 Jun 16702350031 Mar 16695340031 Dec 15689320030 Sep 15683310030 Jun 156773000양질의 수익: QOL는 고품질 수익을 보유하고 있습니다.이익 마진 증가: QOL의 현재 순 이익률 (9.2%)은 지난해 (9%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: QOL의 수익은 지난 5년 동안 연평균 10.4% 증가했습니다.성장 가속화: 지난 1년간 QOL 의 수익 증가율(13.1%)은 연간 평균(10.4%)을 초과합니다.수익 대 산업: QOL의 지난 1년 수익 증가율(13.1%)은 Chemicals 업계의 -2.4%를 상회했습니다.자기자본이익률높은 ROE: QOL의 자본 수익률(14.8%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/06 07:04종가2026/05/06 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스SOL S.p.A.는 7명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Paola SagliettiBanca Akros S.p.A. (ESN)Davide ZappaBanca Akros S.p.A. (ESN)Catharina ClaesBerenberg4명의 분석가 더 보기
Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 22%After last week's 22% share price gain to €59.40, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 145% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €24.91 per share.
공지 • Mar 30SOL S.p.A., Annual General Meeting, May 12, 2026SOL S.p.A., Annual General Meeting, May 12, 2026, at 11:00 W. Europe Standard Time.
Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
공지 • Mar 27SOL S.p.A. announces Annual dividend, payable on May 20, 2026SOL S.p.A. announced Annual dividend of EUR 0.4500 per share payable on May 20, 2026, ex-date on May 18, 2026 and record date on May 19, 2026.
New Risk • Sep 18New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Share price has been volatile over the past 3 months (7.3% average weekly change).
Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • May 12Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 19 May 2025. Payment date: 21 May 2025. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (3.9%).
Declared Dividend • Mar 31Dividend increased to €0.39Dividend of €0.39 is 5.4% higher than last year. Ex-date: 19th May 2025 Payment date: 21st May 2025 Dividend yield will be 1.1%, which is lower than the industry average of 6.1%. Sustainability & Growth The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 32% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공지 • Mar 30SOL S.p.A. announces Annual dividend, payable on May 21, 2025SOL S.p.A. announced Annual dividend of EUR 0.3900 per share payable on May 21, 2025, ex-date on May 19, 2025 and record date on May 20, 2025.
Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.
Upcoming Dividend • May 13Upcoming dividend of €0.37 per shareEligible shareholders must have bought the stock before 20 May 2024. Payment date: 22 May 2024. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%).
New Risk • Mar 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Sep 17New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 47% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.
Upcoming Dividend • May 15Upcoming dividend of €0.33 per share at 1.2% yieldEligible shareholders must have bought the stock before 22 May 2023. Payment date: 24 May 2023. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%).
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Sep 18Second quarter 2022 earnings released: EPS: €0.35 (vs €0.26 in 2Q 2021)Second quarter 2022 results: EPS: €0.35 (up from €0.26 in 2Q 2021). Revenue: €357.9m (up 28% from 2Q 2021). Net income: €32.1m (up 36% from 2Q 2021). Profit margin: 9.0% (up from 8.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • May 09Upcoming dividend of €0.24 per shareEligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (4.2%). Lower than average of industry peers (5.2%).
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공지 • Apr 08SOL S.p.A. announced that it has received €75 million in funding from The Prudential Insurance Company of America, Prudential Legacy Insurance Company of New Jersey, Prudential Term Reinsurance Company, Pruco Life Insurance Company, Gibraltar Universal Life Reinsurance CompanyOn April 6, 2022, SOL S.p.A. closed the transaction.
Reported Earnings • Sep 18Second quarter 2021 earnings released: EPS €0.26 (vs €0.23 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: €280.7m (up 17% from 2Q 2020). Net income: €23.7m (up 15% from 2Q 2020). Profit margin: 8.4% (down from 8.6% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 18Full year 2020 earnings released: EPS €1.19 (vs €0.58 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €987.1m (up 7.5% from FY 2019). Net income: €108.2m (up 107% from FY 2019). Profit margin: 11% (up from 5.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • May 17Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 24 May 2021. Payment date: 26 May 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.3%). Lower than average of industry peers (3.6%).
Upcoming Dividend • May 10Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 17 May 2021. Payment date: 19 May 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.5%).
Is New 90 Day High Low • Feb 19New 90-day high: €15.55The company is up 30% from its price of €11.95 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Jan 26New 90-day high: €14.25The company is up 31% from its price of €10.90 on 27 October 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period.
Is New 90 Day High Low • Jan 05New 90-day high: €14.10The company is up 18% from its price of €12.00 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.
Is New 90 Day High Low • Dec 07New 90-day high: €12.90The company is up 25% from its price of €10.35 on 08 September 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Nov 19New 90-day high: €12.05The company is up 15% from its price of €10.45 on 21 August 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Oct 07New 90-day high: €12.00The company is up 17% from its price of €10.30 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Sep 18New 90-day high: €11.15The company is up 9.0% from its price of €10.20 on 19 June 2020. The German market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period.